Progyny is a medical - healthcare information services company in the healthcare sector trading on NASDAQ, led by CEO David J. Schlanger, with a market cap of $1.4B.
Common questions about Progyny
Progyny is scheduled to report earnings for Q1 2026 on May 7, 2026 after market close. Analysts estimate revenue of $326.5M.
Progyny has approximately 566 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.